Compare ELIZAOS (ELIZAOS) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ELIZAOS vs Mira — how do they compare? ELIZAOS trades at Rp4.03 (market cap Rp38,85M, Rp117,4M 24h volume), while Mira trades at Rp698.28 (market cap Rp224,75M, Rp102,62M 24h volume). The key difference: Mira is far larger — about 5.8× ELIZAOS's market cap, and ELIZAOS's circulating supply is 9,5B / 11B ELIZAOS (87%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold ELIZAOS for 8 Days and Mira for 22 Days on average.
| ELIZAOS | MIRA | |
|---|---|---|
Market Cap | Rp38,85M | Rp224,75M |
Volume (24h) | Rp117,4M | Rp102,62M |
Circulating Supply | 9,5B / 11B ELIZAOS (87%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 8 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ELIZAOS is trading at Rp4.11 with a market cap of Rp38.85M, showing bearish technical signals from moving averages while oscillators remain neutral. The token has 87% of its maximum 11M supply in circulation with an average hold time of 8 days. Current technical analysis indicates weak momentum with RSI levels showing mixed signals and ADX suggesting strong trend direction.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in potential oversold conditions indicated by RSI_12 at 27.40. Major risks include low liquidity, high volatility, and limited exchange support. Investors should monitor for protocol updates and increased trading volume as potential catalysts.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ELIZAOS
elizaOS is an open-source framework for building autonomous AI agents that can read data, make decisions, and take action across blockchains and the web. In its latest version, agents are built from modular plugins, enabling workflows that connect wallets, DeFi protocols, off-chain APIs, and messaging channels.
Read more on ELIZAOS →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
